Pathophysiological Study of the Sensitive Scalp
NCT07156422 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-05-08
Summary
Sensitive skin is defined as a syndrome manifested by the occurrence of unpleasant sensations (tingling, burning, pain, pins and needles) in response to stimuli that should not normally cause them. These unpleasant sensations cannot be explained by lesions attributable to a specific skin disease. Sensitive skin can affect different parts of the body. The scalp is a site that is often affected, with specificity linked in particular to the presence of hair and different triggering factors (styling habits, wearing of head coverings, application of cosmetics to the scalp, etc.). Sensitive scalp affects around half the population, and can have an impact on the quality of life of sufferers, particularly those whose symptoms are very intense. Women are more likely than men to have a sensitive scalp, so in order to have a more homogenous study population, we chose to include 40 women. The pathophysiology of sensitive skin is imperfectly understood, and studies specific to the sensitive scalp are very rare. However, the pathophysiology of the sensitive scalp could be different because it is a hairy area, more innervated, and less exposed to environmental factors.
Conditions
- Sensitive Scalp
Interventions
- PROCEDURE
-
A scalp biopsy using a 4 mm punch in the retroauricular hair zone
a scalp biopsy using a 4 mm punch in the retroauricular hair zone under local anesthesia
- OTHER
-
a general health questionnaire
a general health questionnaire : demographics, history, treatment, smoking, alcohol consumption, phototype.
- OTHER
-
Questionnaires concerning their sensitive scalp
* The characteristics of a sensitive scalp (location, chronicity, triggering and soothing factors, use of cosmetics, etc.) * Sensitive Scalp Score (3S) * Impact on quality of life: BoSS questionnaire * Impact of pruritus on quality of life (ItchyQol)
- PROCEDURE
-
Collection of skin microbiota
The skin microbiome is collected using a sterile swab rubbed against the scalp for 60 seconds
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-28
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- France
Study Locations
More Related Trials
-
Pleiotropic Role of TRPV1 in Psoriasis Inflammation
NCT04848194 ·Status: COMPLETED ·Phase: NA
-
Trichoscopy and Systemic Scleroderma
NCT04804930 ·Status: RECRUITING
-
Defects of Keratinocytes Function in Dermatologic Patients
NCT06324552 ·Status: RECRUITING
-
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
NCT02975271 ·Status: TERMINATED ·Phase: PHASE2
-
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
NCT01044043 ·Status: COMPLETED
-
Swiss Itch Registry
NCT06120907 ·Status: RECRUITING
-
Skin Denervation in Systemic Lupus Erythematosus
NCT00155532 ·Status: COMPLETED ·Phase: PHASE1
-
Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients
NCT02833909 ·Status: COMPLETED ·Phase: NA
-
Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study
NCT01554540 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Skin Cancer in Swiss Transplant Cohort Study
NCT02361229 ·Status: UNKNOWN
-
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
NCT03957681 ·Status: COMPLETED ·Phase: PHASE3
-
Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.
NCT03211325 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking
NCT05532865 ·Status: RECRUITING
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
NCT06177353 ·Status: RECRUITING
-
Characteristics and the Future of the City Chilblains
NCT03101761 ·Status: COMPLETED
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
NCT04213261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma
NCT04319120 ·Status: RECRUITING
-
Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.
NCT04356755 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Safety of Colchicine
NCT05335148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa
NCT04217538 ·Status: COMPLETED
-
Coagulopathy of Immunodermatologic Diseases
NCT06037187 ·Status: RECRUITING
-
Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis
NCT02652065 ·Status: COMPLETED ·Phase: NA
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA
-
Impact of Staphylococcus Aureus on Folliculitis Decalvans
NCT02157688 ·Status: COMPLETED